Author Topic: Roche faces UK pricing row over Ocrevus (Read 151 times)

agate · « **on:** September 10, 2018, 02:19:35 pm »

The NICE people, responsible for who gets what medicines through the UK's health service, have decided that Ocrevus for PPMS isn't "cost effective," and so Ocrevus will be covered for RRMS but not for PPMS in the UK unless this matter can be settled differently:

https://www.reuters.com/article/us-roche-britain/roche-faces-uk-pricing-row-over-multiple-sclerosis-drug-ocrevus-idUSKCN1LP0UX

agate · « **Reply #1 on:** November 03, 2018, 07:59:00 am »

The NICE people have decided to postpone their decision on whether to cover Ocrevus for PPMS in the UK, and that is good news for those with PPMS who have been hoping to be able to obtain this drug.

From Multiple Sclerosis News Today, November 2, 2018--"NICE postpones 'final opinon' on adding Ocrevus to NHS for PPMS patients in UK":

https://multiplesclerosisnewstoday.com/2018/11/02/nice-postpones-final-opinion-on-adding-ocrevus-to-nhs-for-ppms-patients-in-uk/

Subject / Started by	Replies	Last post
FDA approval of Ocrevus (ocrelizumab) delayed Started by agate OCREVUS (ocrelizumab)	1 Replies 171 Views	February 23, 2017, 03:37:23 pm by agate
Rituxan not exactly the same as Ocrevus Started by agate OCREVUS (ocrelizumab)	1 Replies 245 Views	June 14, 2017, 10:35:24 am by agate
One person's experience with Ocrevus Started by agate OCREVUS (ocrelizumab)	0 Replies 112 Views	July 22, 2017, 04:28:55 pm by agate
NEPAD and Ocrevus Started by agate OCREVUS (ocrelizumab)	0 Replies 128 Views	February 19, 2018, 07:47:49 am by agate
Roche touts Ocrevus benefits in treating MS early--competing with Kesimpta Started by agate TREATMENTS	0 Replies 45 Views	August 20, 2022, 09:06:10 pm by agate

MS Speaks